Previous studies from our laboratory on skin cancer cells by knockdown of either p21 or wild-type p53 did not change G2/M phase arrest caused by α-santalol treatment in p53 mutated A431 and p53 wild-type UACC-62 cells [15]. Here, TP53 is linked to skin cancer.